日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6

细胞周期蛋白D-CDK4/6对免疫CD155-CD226-TIGIT轴的调控

Fassl, Anne; Palacios Espinoza, Miriam; Butter, Deborah; Kolodziejczyk, Aleksandra; Seehawer, Marco; Hill, Charlotte; Ning, Xiaohan; Branigan, Timothy B; Peñailillo, Johany; Saengboonmee, Charupong; Jadhav, Heta; Charbonnier, Louis-Marie; Waks, Adrienne G; Strawser, Corinne; McDonnell, Donald P; Shapiro, Geoffrey I; Tolaney, Sara M; Polyak, Kornelia; Sammons, Sarah; Wucherpfennig, Kai W; Sicinski, Piotr

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data

探讨淋巴结阳性、高危、激素受体阳性、HER2阴性早期乳腺癌患者的治疗差距和预后风险:真实世界数据分析

Tolaney, S M; Sammons, S; Sandoval-Leon, A; Cortes, J; Liepa, A M; Grimes, B R; He, D; Cui, Z L; Roose, J; Gathirua-Mwangi, W; Moreira, K; O'Shaughnessy, J; Neven, P; Johnston, S R D; Rugo, H S

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

定量 HER2 组织和血浆分析可预测曲妥珠单抗 deruxtecan 对乳腺癌的活性。

Tarantino Paolo, Kim Se-Eun, Hughes Melissa E, Kusmick Ross J, Smith Kalie, Brasó-Maristany Fara, Nyein Chan Nay Nwe, Paré Brunet Laia, Alder Laura, Garcia-Cortes Diana, Gomez Tejeda Zanudo Jorge, Pereslete Alyssa M, Noteware Laura, Moore Heather, Van Swearingen Amanda E D, Li Tianyu, Gupta Hersh, D'Amico Olivia, Martini Alba, Morganti Stefania, Spindel Jennifer, Cook Charmaine, McLaughlin Christine, Dvir Kathrin, Garrido-Castro Ana C, Sammons Sarah, Files Janet, Sendrick Kerry, Buck Simone, Dillon Deborah, Jeselsohn Rinath, Li Yvonne Y, Cherniack Andrew D, LoRusso Patricia, Lustberg Maryam, Vega-León Rosario, Pardo Francisco, Davis Justin, Mueller Claudius, Corgiat Brian, Curigliano Giuseppe, Anders Carey K, Petricoin Emanuel F, Rimm David L, Prat Aleix, Tayob Nabihah, Lin Nancy U, Tolaney Sara M

The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)

新诊断的浸润性乳腺癌和导管原位癌(DCIS)患者肠道微生物组概况

Sammons, Sarah L; Kuntz, Thomas M; DiLullo, Molly; Morgan, Xochitl C; Martin, Alyssa; Hughes, Melissa E; Rahman, Tasnim; Barroso-Sousa, Romualdo; Ogayo, Esther Ritah; Giordano, Julia; Ryan, Sean; Waks, Adrienne G; Schlam, Ilana; Ligibel, Jennifer; Lin, Nancy U; Garrido-Castro, Ana C; Mittendorf, Elizabeth A; Tolaney, Sara M

Identification of small molecules that enhance aminoglycoside-mediated suppression of CFTR and NF1 nonsense mutations.

鉴定能增强氨基糖苷类药物对 CFTR 和 NF1 无义突变抑制作用的小分子。

Sammons Joshua, Chen Jianguo, Thrasher Kari, Fu Lianwu, Du Ming, Wen Hui, Bostwick J Robert, Vinson Paige, Moukha-Chafiq Omar, Augelli-Szafran Corinne, Keeling Kim M, Wallis Deeann, Kesterson Robert A, Rowe Steven M, Bedwell David M

Ser500 phosphorylation acts as a conformational switch to prime eEF-2K for activation

Ser500 磷酸化作为一种构象开关,启动 eEF-2K 的激活。

Bohanon, Amanda L; Browning, Luke S; Piserchio, Andrea; Long, Kimberly J; Jacob, Sharon; Sammons, Rae M; Tavares, Clint D J; Cho, Eun Jeong; Ghose, Ranajeet; Dalby, Kevin N

Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer

调查 CDK4/6 抑制剂在 HR+/HER2- 晚期乳腺癌中的真实世界证据和已报道的生存结果

Sammons, Sarah; Yardley, Denise A; Sharma, Priyanka; Gadi, Vijayakrishna K; Pegram, Mark; Pathak, Purnima; Hu, Huilin; Sopher, Gary; Fasching, Peter A

Health System Community Partnership to Design an Online Resource to Address Perinatal Information Needs for Black Families: Action Research Study

卫生系统社区合作设计在线资源以满足黑人家庭围产期信息需求:行动研究

Taylor, Yhenneko J; Dahl, Alicia; Isreal, McKenzie; Spinner, Chelse; Sammons, Lisa; Fesperman, Daniel; Washington, Racquel; Mehta, Shivani; Howell, Candace; Stamp, Jennifer; Bundy, Henry; Cobb, Pamela

SCANBIT facilitates identification of tumor cell populations in scRNAseq data using pseudobulked SNV calls

SCANBIT 利用伪批量 SNV 调用,有助于识别 scRNAseq 数据中的肿瘤细胞群。

Mv, Cannon; Mj, Gust; Ac, Gross; M, Cam; Jb, Reinecke; L, Jimenez Garcia; Ch, Strawser; L, Ryan; M, Sammons; Zhang, C Z; Rd, Roberts

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial

阿贝西利联合氟维司群治疗CDK4/6抑制剂治疗进展后的晚期乳腺癌:MONARCH III期临床试验结果

Kalinsky, Kevin; Bianchini, Giampaolo; Hamilton, Erika; Graff, Stephanie L; Park, Kyong Hwa; Jeselsohn, Rinath; Demirci, Umut; Martin, Miguel; Layman, Rachel M; Hurvitz, Sara A; Sammons, Sarah; Kaufman, Peter A; Muñoz, Montserrat; Lai, Jiun-I; Knoderer, Holly; Sandoval, Cynthia; Chawla, Aarti R; Nguyen, Bastien; Zhou, Yanhong; Ravenberg, Elizabeth; Litchfield, Lacey M; Smyth, Lillian; Wander, Seth A